Sidley’s European Life Sciences practice provides comprehensive EU, Swiss, German, and UK regulatory, litigation, and transactional support for a broad range of life sciences companies, including biopharma, medical devices, animal health, food technology, software, consumer products, and platform services. Sidley advises on cutting-edge regulatory, compliance, and competition issues for established and emerging life sciences companies, as well as acting on cases with wide-ranging regulatory implications before national and European courts.